GigaMune
PrivateLast Round
Grant
Sep 15, 2025
Total Funding Raised
$400,000
Momentum Score
50 /100
Company Overview
GigaMune is a biotechnology company developing a pipeline of in vivo cell therapies for cancer and inherited blood disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GigaMune Comps
Public and private peers based on sector, stage, and business model.
GigaMune Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 15, 2025 | ||||
| Pre Seed | May 30, 2023 | ||||
| Grant | Aug 1, 2021 | ||||
| Convertible Debt | Apr 12, 2019 |
GigaMune Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Newsight Tech Angels | Pre Seed |
| Bioverge | Pre Seed |
| Sand Hill Angels | Pre Seed |
| Boost VC | Pre Seed |
| Reinforced Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors increased 61% MoM.
- Sep 15, 2025
$400K round led by the National Cancer Institute.
GigaMune Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GigaMune's valuation, stock price, and market status.
